D.E. Shaw & Co’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-49,605
| Closed | -$1.39M | – | 6030 |
|
|
2022
Q1 | $1.39M | Sell |
49,605
-47,159
| -49% | -$1.29M | ﹤0.01% | 3635 |
|
|
2021
Q4 | $2.64M | Sell |
96,764
-73,740
| -43% | -$2M | ﹤0.01% | 3098 |
|
|
2021
Q3 | $4.64M | Sell |
170,504
-150,870
| -47% | -$3.73M | ﹤0.01% | 2171 |
|
|
2021
Q2 | $5.49M | Sell |
321,374
-28,766
| -8% | -$538K | ﹤0.01% | 1956 |
|
|
2021
Q1 | $7.31M | Sell |
350,140
-95,793
| -21% | -$2.21M | 0.01% | 1580 |
|
|
2020
Q4 | $10.2M | Sell |
445,933
-30,844
| -6% | -$587K | 0.01% | 1374 |
|
|
2020
Q3 | $7.78M | Sell |
476,777
-111,553
| -19% | -$2.02M | 0.01% | 1405 |
|
|
2020
Q2 | $7.97M | Buy |
588,330
+415,761
| +241% | +$4.84M | 0.01% | 1328 |
|
|
2020
Q1 | $2.04M | Sell |
172,569
-287,563
| -62% | -$6.38M | ﹤0.01% | 2148 |
|
|
2019
Q4 | $11.5M | Buy |
460,132
+221,917
| +93% | +$4.5M | 0.01% | 1114 |
|
|
2019
Q3 | $4.05M | Buy |
238,215
+99,606
| +72% | +$1.81M | 0.01% | 1815 |
|
|
2019
Q2 | $3.15M | Sell |
138,609
-56,090
| -29% | -$1.51M | ﹤0.01% | 1927 |
|
|
2019
Q1 | $6.26M | Buy |
194,699
+64,473
| +50% | +$2M | 0.01% | 1398 |
|
|
2018
Q4 | $3.67M | Buy |
130,226
+15,515
| +14% | +$454K | 0.01% | 1718 |
|
|
2018
Q3 | $3.3M | Buy |
114,711
+31,888
| +39% | +$958K | ﹤0.01% | 1846 |
|
|
2018
Q2 | $3.1M | Buy |
82,823
+52,763
| +176% | +$2.07M | ﹤0.01% | 1896 |
|
|
2018
Q1 | $1.18M | Sell |
30,060
-63,451
| -68% | -$2.32M | ﹤0.01% | 2381 |
|
|
2017
Q4 | $3.03M | Sell |
93,511
-43,969
| -32% | -$1.32M | ﹤0.01% | 1843 |
|
|
2017
Q3 | $4.28M | Buy |
137,480
+12,243
| +10% | +$362K | 0.01% | 1490 |
|
|
2017
Q2 | $3.5M | Buy |
125,237
+84,757
| +209% | +$1.92M | 0.01% | 1602 |
|
|
2017
Q1 | $694K | Buy |
40,480
+7,663
| +23% | +$107K | ﹤0.01% | 2553 |
|
|
2016
Q4 | $397K | Sell |
32,817
-14,943
| -31% | -$193K | ﹤0.01% | 2985 |
|
|
2016
Q3 | $757K | Buy |
+47,760
| New | +$719K | ﹤0.01% | 2569 |
|
|
2016
Q2 | – | Sell |
-20,894
| Closed | -$397K | – | 3602 |
|
|
2016
Q1 | $397K | Sell |
20,894
-108,893
| -84% | -$1.97M | ﹤0.01% | 2899 |
|
|
2015
Q4 | $2.92M | Sell |
129,787
-53,955
| -29% | -$1.07M | ﹤0.01% | 1832 |
|
|
2015
Q3 | $4.3M | Buy |
183,742
+51,940
| +39% | +$1.43M | 0.01% | 1511 |
|
|
2015
Q2 | $3.77M | Buy |
131,802
+79,128
| +150% | +$2.07M | 0.01% | 1690 |
|
|
2015
Q1 | $1.36M | Buy |
52,674
+22,162
| +73% | +$507K | ﹤0.01% | 2315 |
|
|
2014
Q4 | $566K | Buy |
30,512
+1,426
| +5% | +$25.7K | ﹤0.01% | 3236 |
|
|
2014
Q3 | $451K | Buy |
+29,086
| New | +$438K | ﹤0.01% | 3428 |
|
D.E. Shaw & Co's XENT Position: Q2 2022 in Review
D.E. Shaw & Co sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 49,605 shares — an estimated $1.39M sold.
D.E. Shaw & Co first reported a position in XENT in Q3 2014 and held it in 30 quarters. The position peaked at $11.5M in Q4 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- D.E. Shaw & Co reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 49,605 Intersect ENT, Inc shares in Q2 2022, an estimated $1.39M.
- D.E. Shaw & Co first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 30 quarters.
- D.E. Shaw & Co's Intersect ENT, Inc position peaked at $11.5M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on D.E. Shaw & Co's 13F filing for Q2 2022, filed 15 Aug 2022.